ANRO: Alto Neuroscience, Inc. Stock

by  •  • Comments Off on ANRO: Alto Neuroscience, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 379.57
Enterprise Value ($M) 449.71
Book Value ($M) 71.16
Book Value / Share 2.65
Price / Book 5.33
NCAV ($M) 69.92
NCAV / Share 2.60
Price / NCAV 5.43

Profitability (mra)
Return on Invested Capital (ROIC) -0.45
Return on Assets (ROA) -0.71
Return on Equity (ROE) -1.02

Liquidity (mrq)
Quick Ratio 15.22
Current Ratio 15.22

Balance Sheet (mrq) ($M)
Current Assets 85.39
Assets 86.63
Liabilities 15.47
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -37.81
Net Income -36.30

Cash Flow Statement (mra) ($M)
Cash From Operations -33.45
Cash from Investing -0.47
Cash from Financing 68.13

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-29 13G Ra Capital Management, L.p. 5.20
02-09 13G Falcon Edge Capital, LP 13.80
02-07 13G Point72 Asset Management, L.P. 6.30

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 4,259 20,171 21.11
2024-04-25 8,768 41,908 20.92
2024-04-24 8,369 36,767 22.76
2024-04-23 30,111 85,381 35.27
2024-04-22 21,662 82,863 26.14

(click for more detail)

Similar Companies
ABBV – AbbVie Inc. ABT – Abbott Laboratories
ADCT – ADC Therapeutics SA ANVS – Annovis Bio, Inc.
BHC – Bausch Health Companies Inc.


Financial data and stock pages provided by
Fintel.io